Enzymes in heteromeric, allosterically regulated complexes catalyze a rich array of chemical reactions. Separating the subunits of such complexes, however, often severely attenuates their catalytic activities, because they can no longer be activated by their protein partners. We used directed evolution to explore allosteric regulation as a source of latent catalytic potential using the β-subunit of tryptophan synthase from Pyrococcus furiosus (PfTrpB). As part of its native αββα complex, TrpB efficiently produces tryptophan and tryptophan analogs; activity drops considerably when it is used as a stand-alone catalyst without the α-subunit. Kinetic, spectroscopic, and X-ray crystallographic data show that this lost activity can be recovered by mutations that reproduce the effects of complexation with the α-subunit. The engineered PfTrpB is a powerful platform for production of Trp analogs and for further directed evolution to expand substrate and reaction scope.
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protein engineering | allostery | noncanonical amino acid | PLP H eteromeric enzyme complexes catalyzing a rich array of useful reactions are often allosterically regulated by their protein partners, such that the catalytic subunits are much less active when isolated (1) (2) (3) . Utilization of isolated enzyme subunits, however, is desirable for biosynthetic applications, where expressing large complexes increases the metabolic load on the host cell and complicates efforts to engineer activity, substrate specificity, stability, and other properties. A solution to these problems is to engineer the isolated subunit to function independently. However, it is unknown to what extent mutations in the amino acid sequence can reproduce the complex structural and functional changes that are induced by binding of a partner protein.
Tryptophan synthase (TrpS; EC 4.2.1.20) is a heterodimeric complex that catalyzes the formation of L-tryptophan (Trp, 1) from L-serine (Ser, 2) and indole glycerol phosphate (IGP, 3; Fig.  1A ) (2) . The mechanism of this transformation has been extensively studied for TrpS from Escherichia coli and Salmonella typhimurium, where it has been shown the enzyme consists of two subunits, TrpA (α-subunit) and TrpB (β-subunit), both of which have low catalytic efficiencies in isolation (4) . The activities of both subunits increase upon complex formation and are further regulated by an intricate and well-studied allosteric mechanism (2) . IGP binding to the α-subunit stimulates pyridoxal phosphate (PLP)-dependent aminoacrylate formation in the β-subunit [E(A-A); Fig. 1B ], which in turn promotes retro-aldol cleavage of IGP in the α-subunit, releasing indole (4) . This tightly choreographed mechanism serves to prevent the free diffusion of indole, which is only released from the α-subunit when the complex is in a closed conformation that forms a 25-Å tunnel through which indole diffuses into the β-subunit (5). Here, indole reacts with E(A-A) in a C-C bond-forming reaction, yielding L-tryptophan as product (Fig. 1B) (2, 5) . These allosteric effects are mediated through the rigid-body motion of the communication (COMM) domain and a monovalent cation (MVC) binding site within the β-subunit (Fig. 1A) , which undergo complex conformational transitions associated with open, partially closed, and fully closed states during the catalytic cycle (2, 4, 6) .
TrpS is a naturally promiscuous enzyme complex: the model system from S. typhimurium catalyzes its β-substitution reaction with most haloindoles, methylindoles, and aminoindoles, along with an assortment of nonindole nucleophiles for C-S, C-N, and C-C bond formation (7) . Such noncanonical amino acids (NCAAs) have diverse applications in chemical biology (8) , serve as intermediates in the synthesis of natural products (9, 10) , and are privileged scaffolds for the development of pharmaceuticals (11) . Despite its natural ability to produce these desirable compounds, TrpS has enjoyed only limited application (7) . Optimized methods are restricted by low substrate concentrations and yields typically below 50% (7, 12, 13) . To produce NCAAs, researchers have used the S. typhimurium TrpS complex (StTrpS), which suffers from poor thermostability and low tolerance to organic solvents (14) . Although only the reactivity of the β-subunit, coupling of L-serine and indole, is necessary and desirable for synthetic applications, using TrpB as an isolated enzyme has not been feasible. Outside of its native complex, TrpB loses up to 95% of its native activity and is subject to inactivation (15, 16) . These facts combine to present a compelling challenge: can we use directed evolution to recover the activity lost when TrpA is removed and create a highly active stand-alone TrpB enzyme? If so, what are the structural and kinetics effects of the mutations that harness this latent catalytic potential?
Significance
Many enzymes perform desirable biochemical transformations, but are not suitable to use as biocatalysts outside of the cell. In particular, enzymes from heteromeric complexes typically have decreased activity when removed from their protein partners. We used directed evolution to restore the catalytic efficiency of the tryptophan synthase β-subunit (TrpB), which synthesizes L-tryptophan from L-serine and indole, surpassing the activity of the native complex. Experiments show that activating mutations promote catalysis through the same mechanism as partner protein binding, establishing that isolated subunits may be readily reactivated through directed evolution. Engineering TrpB for stand-alone function restored high activity with indole analogs, providing a simplified enzyme platform for the biocatalytic production of noncanonical amino acids.
Results
Selection of the Parent Enzyme, TrpB, from Pyrococcus furiosus. We focused the search for an engineering starting point on known thermophilic TrpS enzymes for three reasons: (i) higher operating temperatures afford increased solubility of the hydrophobic substrates, which is useful for preparative reactions; (ii) thermostable enzymes are more tolerant to the introduction of activating but potentially destabilizing mutations (17) ; and (iii) thermostable enzyme variants can be screened efficiently (described below). We compared published kinetic properties of TrpS from Thermotoga maritima (18), Thermococcus kodakaraensis (19) , and Pyrococcus furiosus (20) (21) (22) and selected the last for its superior kinetic parameters and thermostability (Table S1 ). In our hands, PfTrpB heterologously expressed and purified from E. coli has a k cat of 0.31 s −1 and experiences a 12-fold increase in catalytic efficiency upon addition of purified P. furiosus TrpA (PfTrpA) to make the PfTrpS complex (Table 1) , similar to values reported previously for E. coli TrpB (EcTrpB) (15) . Notably, PfTrpB does not show the mechanism-based inactivation that inhibits use of StTrpB for preparation of NCAAs (23) .
Directed Evolution of PfTrpB for Stand-Alone Function. We performed random mutagenesis by error-prone PCR and screened a small PfTrpB mutant library (528 clones) for increased V max under saturating concentrations of substrate (L-serine and indole). The extreme thermostability of the parent enzyme permitted a 1-h heat treatment of the lysates at high temperature (75°C) that precipitated the majority of E. coli proteins and ensured that any activated variants retained significant stability. Formation of L-tryptophan took place at 75°C for up to 1 h (generation 1, 1 h; generations 2 and 3, 6 min). The reactions were then quenched in an ice-water bath, and the production of L-tryptophan was quantified at 290 nm with a plate reader. This procedure identified many activating mutations, with 3.8% (20/528) of the screened variants of generation 1 showing at least 40% greater product formation than the parent. A single mutation, T292S, gave rise to a 3.5-fold increase in k cat compared with PfTrpB, which completely recovered k cat and even exceeded the catalytic efficiency (k cat /K M ) of the PfTrpS complex (Table 1) . Twenty-six other mutations in 19 different variants also contributed activating effects (Fig. S1) .
We recombined 12 of the most activating mutations identified in the first generation (SI Materials and Methods). Screening a total of 1,408 clones, we identified PfTrpB 4D11 containing mutations E17G, I68V, F274S, T292S, and T321A. The k cat of PfTrpB 4D11 was 2.2 s −1 , a sevenfold improvement over wild type (Table 1) . PfTrpB 4D11 served as template for a final round of random mutagenesis, for which we screened 1,144 clones. PfTrpB 0B2 carried one additional mutation, P12L, and had a k cat that was 9.4-fold higher than PfTrpB and threefold higher than PfTrpS. With PfTrpB 0B2 we had surpassed our goal of engineering an isolated enzyme domain to be as active as in its native complex.
Biochemical Comparison of Evolved PfTrpB Enzymes with PfTrpS.
Kinetic analysis of PfTrpB and PfTrpS established that the 12-fold increase in the catalytic efficiency for indole upon complexation is driven by both an increase in k cat and decrease in K M (Table 1) . Despite screening the mutant libraries under saturating All kinetic data are measured at 75°C using a previously described (15) continuous assay for Trp production. Additional mutations relative to their parent enzyme are highlighted in bold. *The effect of PfTrpA was measured by addition of a fivefold stoichiometric excess of PfTrpA under conditions saturating in each substrate. † T 50 is the temperature of half-maximal activity after incubation for 1 h. Assay parameters are described in Materials and Methods. SE for each measurement is given in Table S2 .
conditions for both substrates, we observed a steady decrease in the K M for indole in the enzymes with greater activity, which mimics the behavior of the native complex. The K M for L-serine fluctuated during evolution, and in the final round the values for PfTrpB 0B2 and PfTrpS were similar. Though Michaelis-Menten kinetic analysis provides a simple readout of overall catalytic performance, activity changes upon complex formation and during directed evolution are associated with a shift in the populations of the intermediates in the TrpB catalytic cycle. The PLP cofactor absorbs in the UV-vis region, and different chemical intermediates have characteristic peaks that can be measured readily (Fig. 1B) . Under turnover conditions, the recorded spectrum reflects the Boltzmann-weighted average of each of the intermediates in the catalytic cycle. Incubation of PfTrpB with L-serine results in a large increase in absorption at 428 nm, consistent with accumulation of E(Aex 1 ) ( Fig. 2A) . A peak at 320 nm developed over several minutes, whereas the absorption at 428 nm remained constant (Fig. S2) , which we attribute to the previously characterized serine deaminase activity that is an artifact of not having a competing nucleophile present (24) . In contrast, L-serine-bound PfTrpS has a λ max near 350 nm, consistent with a shift in the equilibrium to populate the E(A-A) (Fig. 2B) (2) . With the engineered proteins, the external aldimine absorbance at 428 nm decreases, and the absorbance bands at 350 nm grow in intensity over the course of directed evolution of Trp synthase activity ( Fig. 2C and Fig. S2) .
One question motivating this study was how mutational reactivation alters the allosteric regulation of PfTrpB by its TrpA protein partner. Adding purified PfTrpA to each TrpB variant gave a surprising result: instead of enhancing activity (or doing nothing), PfTrpA inhibited each improved TrpB, an effect that was stronger with each evolutionary step, to the point where PfTrpB 0B2 had just 4% of its activity when PfTrpA was added (Table 1) .
Structural Analysis of PfTrpB. Whereas the residues that perform the TrpB chemistry are conserved throughout evolution, the conformational motions associated with allosteric signaling have not been characterized outside of StTrpS or in the absence of the α-subunit. We obtained high-resolution structures of wild-type PfTrpB in its ligand-free state, bound to its L-serine substrate, and bound to its L-tryptophan product (Table S3) . Comparison of the ligand-free and Ser-bound structures (at 1.69 Å and 2.0 Å resolution, respectively) reveals motion of the COMM domain into a partially closed state upon serine binding, as well as a hydrogen bond between Asp300 and the Ser-hydroxyl of E(Aex 1 ) (Fig. 3 A and B) . This large conformational rearrangement is structurally equivalent to that characterized for StTrpS (25), with 0.5 Å rmsd between the E(Aex 1 ) forms of TrpB (Fig. S3) , despite the modest (59%) sequence identity and lack of an α-subunit. Combined with their similar biochemical properties, this structural conservation constitutes firm experimental support for applying insights gleaned from StTrpS and EcTrpS to the function of PfTrpB. Labeling studies have shown that β-substitution occurs with retention of stereochemistry, indicating the hydroxyl of E(Aex 1 ) must rotate 180°from its crystallographically observed state to eliminate from the same face to which indole is added (26) . The H-bond between E(Aex 1 ) and Asp300 is, therefore, transient during the catalytic cycle and suggests an important role for the H-bond between Thr292 and Asp300 that we observed in the ligand-free structure. Notably, T292S was one of the most activating mutations identified in the first round of directed evolution (Fig. 4 A and B and Table 1 ). When L-Ser is incubated with PfTrpB
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, the UV-vis spectrum clearly shows that the equilibrium is shifted toward E(A-A) (Fig. S2B) . We hypothesize that this mutation alters the energetics of the Asp300-E(Aex 1 ) interaction to favor the fully closed conformational state of the enzyme and thereby accelerate the reaction.
The structure of PfTrpB with L-tryptophan bound in the active site at 1.74 Å resolution shows the product is not covalently linked to the PLP cofactor, but is in a novel ligand-binding pose (Fig. 3C) . Residues Thr105 to His110 comprise a carboxylate binding motif (4) that we report also forms H-bonds to the primary amine of L-tryptophan through the backbone N-H of Ala106. This same residue also H-bonds with the Ser-hydroxyl of E(Aex 1 ). Asp300, however, is not observed to interact with L-tryptophan. A hydrogen bond between Glu104 and the N-1 of L-tryptophan likely also occurs when indole binds. This interaction may serve to increase the nucleophilicity of indole by positioning C-3 close to the acrylate of E(A-A) and by increasing electron density of the arene (Fig. 1B) (2, 4) . Glu104 is located in the COMM domain and shifts closer to the active site upon closure (Fig. 3A) . In each of the substrate-and product-bound structures, we observed a rotameric shift of Phe274 and His275 (Fig. 4C) that may function as a gate within the indole tunnel (Fig. 4D) . In the structure of PfTrpS, we observe a hydrogen bond between His275 and Asp43 from the α-subunit, indicating that PfTrpA binding stabilizes this open conformation (Fig. S4A) . In StTrpS, NMR analysis has shown this motion is concerted, and our observation that it is conserved across species is consistent with it having an important role for regulating catalytic function (27) . The location of the F274S mutation is therefore quite striking, because it may alter the energetics of this transition to favor higher activity.
Two mutations, E17G and P12L, map onto the α/β interface of a previously determined 3.0-Å structure of PfTrpS (22), but this low resolution precluded confident assessment of the side-chain interactions for these residues. We solved a higher-resolution structure at 2.76 Å that revealed a salt bridge between Glu17 of PfTrpB and Arg148 of PfTrpA (Fig. S4B) . Pro12 of PfTrpB is an evolutionarily conserved residue that lies along the indole tunnel between the two subunits, where previous studies have found that mutation to bulkier residues inhibits substrate channeling (28) . Such interactions are clearly disrupted at the α/β interface (Fig. S4C) , but the strong inhibition of PfTrpB 0B2 upon PfTrpA addition demonstrates that these proteins still associate. Finally, two mutations present in PfTrpB 0B2 , I68V and T321A, are distal to sites that undergo an observable structural change upon substrate binding or complex formation, and their contribution to rate enhancement is difficult to rationalize. Overall, 60% of the activating mutations identified through random mutagenesis were located within 5 Å of the α/β interface, the COMM domain, or regions that undergo observable motion upon transition to the closed conformation (Fig. S1 ). These positions comprise just 31% of the protein sequence, indicating modest enrichment within residues in the immediate spatial route between the α/β interface and the β-subunit active site. In contrast to the many mutations that have been identified as deleterious to the allosteric communication in TrpS (29, 30) , the mutations identified here using directed evolution are the first reported to affect allosteric communication and increase the activity of TrpB in isolation.
PfTrpB 0B2 Is a Stand-Alone Catalyst for Production of NCAAs. Our selection of TrpB to evolve for high activity outside of its native complex was motivated by practical considerations. Previous studies have shown that StTrpS is a promiscuous enzyme, capable of synthesizing diverse analogs of L-tryptophan (7, 13) . These analogs require subtly different transition state stabilization for catalysis, but the role of allostery in promoting this desirable chemistry has not been studied. We selected a representative panel of substrate analogs to study promiscuous activity in the native and engineered proteins (Fig. 5A) . The StTrpS complex reacts with most halogenated and methylated indoles, which only modestly change the steric and electronic properties of the indole ring and afford reactivity at C3. Alternatively, indazole (5) and indoline (6) , which have substantially altered electronic properties, react at N1 for C-N bond formation. We measured the relative rate of PfTrpB compared with PfTrpS and observed much larger rate enhancements for TrpB on the indole derivatives than on the native substrate (Fig. 5B) , up to a 100-fold increase in the rate of NCAA synthesis with 5-bromoindole (7). These results raised an important question about our objective to engineer PfTrpB for function as an independent subunit by directed evolution: will screening for higher activity with indole translate into increased activity on alternative substrates, or will evolution generate an enzyme that is highly active on indole but less active toward other substrates, as has been observed in directed evolution of other enzymes (31, 32) ?
We measured the activity of PfTrpB 0B2 on the substrate panel (Fig. 5B) and were pleased to observe a substantial increase in activity relative to PfTrpB for all nucleophiles tested. The activity profile is broadly similar to that of PfTrpS, with a few exceptions. The PfTrpS complex reacts approximately eightfold faster than PfTrpB 0B2 with bromoindole 7, whereas PfTrpB 0B2 reacts approximately sixfold faster than PfTrpS with indoline 6 and threefold faster with indazole 5. The identity of each product was confirmed by mass spectrometry and NMR in reactions using PfTrpB 0B2 . Because we screened for increases in V max during laboratory evolution, the variants we selected also have improved expression levels relative to PfTrpB. E. coli cultures produce threefold more soluble and active PfTrpB 0B2 than PfTrpB, exceeding 230 mg enzyme per liter culture, facilitating preparative reactions and future use of PfTrpB 0B2 as a biocatalyst.
Discussion
We evolved PfTrpB for independent function by selecting mutations that increased its V max in heat-treated E. coli lysates. We found that activating mutations were unusually common, which could in part be attributed to the high thermal stability of the parent enzyme that increases tolerance to the introduction of random mutations (17) . However, it is clear that many mutations have the potential to recover activity lost when TrpB is removed from its native complex. The single T292S mutation raised the catalytic efficiency of PfTrpB on indole by almost 20-fold and completely restored activity to TrpS-like levels (Table 1) . Further evolution resulted in the identification of PfTrpB 0B2 , which retained T292S as well as five additional mutations. This variant has an 83-fold increase in catalytic efficiency on indole compared with PfTrpB. The T292S and F274S mutations occur in dynamic regions of TrpB related to catalytic function, as discussed above. However, the majority of the mutations in PfTrpB 0B2 , and 40% of all activating mutations that we identified, are at positions that do not undergo any observable structural changes upon formation of the partially closed state, nor do the corresponding residues in StTrpS move upon formation of the fully closed state (2) . The location of many activating mutations outside of any observed allosteric site raises the central question of this study: did directed evolution increase activity through the same mechanism(s) through which TrpA binding regulates function? If so, we posit that increases in k cat , which was under selective pressure during directed evolution, would be coupled to other kinetic and spectroscopic characteristics of the native complex for which there was no selective pressure.
To a first approximation, the open-close equilibrium of TrpB can be inferred from its K M for indole because TrpA binding stabilizes the closed conformation (2) and decreases the K M (Table 1) . Each generation of evolution of PfTrpB produced a lower K M for indole, to values below those in PfTrpS, despite screening under saturating conditions (Table 1) . UV-vis spectroscopy affords a more-sensitive probe of the active site environment because the steady-state distribution of intermediates in the catalytic cycle can be directly observed. Measurement of the steady-state population of the stage I intermediates in PfTrpB shows that the electrophilic E(A-A) state is stabilized relative to E(Aex 1 ) when PfTrpA binds. This same stabilization of E(A-A) is observed in TrpB enzymes evolved for independent function (Fig. 2) . These data reflect the properties of PfTrpB in its native reaction. Activity on indole analogs is also significantly increased by PfTrpA binding, with the rate enhancements differing by two orders of magnitude between diverse indole analogs (Fig. 5) . Because each of these substrates requires slightly different transition state stabilization, the rate enhancement upon effector addition is a sensitive metric for changes in the conformational ensemble that are relevant to catalysis. Consistent with the data measured on the native reaction, we observed that increases in activity with indole analogs caused by mutation were similar to the effects of TrpA addition (Fig. 5) . Taken together, these data support the hypothesis that increases in PfTrpB activity from directed evolution arose through the same mechanism by which effector binding activates catalysis.
A perplexing observation about mutational reactivation is that addition of PfTrpA to the engineered proteins did not result in allosteric activation, but instead inhibited catalysis. A simple open-closed model of the ensemble might imply that TrpA binding and mutations that stabilize the closed state would be additive in their effects on catalysis. Though the introduction of mutations may change the nature of the allosteric signaling that results from TrpA binding, no such assumption is required to explain the inhibition. It is well documented that stabilization of the closed state by effector binding alters the energetics of multiple transition states of TrpB (2) . These changes in transition-state energy result in a lower overall barrier to the reaction. Doubling these energetic perturbations (e.g., TrpA and the mutations combined) would lower the energy of the original ratelimiting step, but could end up impeding catalysis by increasing the energy of a different step above the original reaction barrier (Fig.  S5) . With this explanation, the inhibitory effect of TrpA becomes consistent with the demonstration that the mutations and effector addition accelerate catalysis through the same mechanism.
Allostery is common in enzymes and has been targeted in previous protein engineering endeavors (vide infra). To compare the role of allostery in these diverse efforts, we define the change in activity that arises through effector binding as an enzyme's allosteric potential. In this view, it has been shown that allosteric potential can be decreased by using mutagenesis to disrupt specific interactions between fructose-1,6-bisphosphatase and its effector, adenosine monophosphate (33) . Recent studies have also shown that engineering can increase allosteric potential, enhancing inhibition of phosphofructokinase by phosphoenolpyruvate (34) . An allosteric potential can even be engineered into enzymes where previously one did not exist (35) . Nature has found mutations that constitutively activate allosterically regulated enzymes, as is well known in phosphorylation cascades contributing to tumorigenesis (36) . Finding such mutations for engineering purposes has proved challenging. The native substrate of the acyl-transferase LovD is covalently bound to an acyl carrier protein, LovF, which also functions as an allosteric activator. LovD was subjected to nine rounds of directed evolution for altered substrate specificity, thermal stability, and tolerance to organic solvent to generate a biocatalyst for production of the drug simvastatin (37) . Insight into whether increases in activity were related to allosteric regulation was gleaned from microsecond molecular dynamics simulations, which suggested that LovF promotes the stability of a closed and catalytically active conformation of LovD and that directed evolution identified mutations that increased activity in a similar fashion (37) . Our kinetic, structural, and spectroscopic data provide firm experimental support for a similar effect in TrpB, demonstrating that allosteric potential can be readily converted into catalytic activity through directed evolution.
We advocate that future efforts to recoup allosteric potential not be limited to making mutations within a hypothetical allosteric pathway (38) . Residues whose interactions are not changed upon effector addition can nonetheless tune the cooperative network of interactions that transfer allosteric signals (39) . More generally, allostery enables proteins to respond to environmental cues, and often only small energetic differences separate active conformations from inactive or less-active ones. The protein ensembles of such enzymes are likely to be sensitive to the effects of widely distributed mutations. Indeed, a single conservative mutation (T292S) was sufficient to raise the catalytic efficiency of PfTrpB to the level of the TrpS complex, and many other mutations contributed smaller activating effects. Therefore, we anticipate that recovering allosteric potential with directed evolution will be broadly achievable.
These insights into the modulation of protein allosteric regulation are of both fundamental and practical interest. Our observation that the activity of PfTrpB was enhanced on a range of substrates is consistent with the hypothesis that the mutations alter transition-state stabilization in a manner similar to PfTrpA binding; it also establishes a greatly simplified enzyme platform for production of NCAAs. This demonstration that isolated subunits may be readily reactivated through directed evolution provides a useful tool for the chemical biology community and expands the scope of enzymes accessible for biocatalysis.
Materials and Methods
Detailed experimental methods are presented in SI Materials and Methods.
Cloning, Expression, and Purification of PfTrpA and PfTrpB. The genes encoding PfTrpB (UNIPROT ID Q8U093) and PfTrpA (UNIPROT ID Q8U094) were obtained as gBlocks and cloned into pET22(b)+ for expression in E. coli BL21 E. cloni EXPRESS cells (Lucigen). Heterologous protein expression of PfTrpA and PfTrpB was performed in Terrific Broth with 100 μg/mL ampicillin (TB amp ) and induced with 500 mM IPTG (final concentration 1 mM). PfTrpB was purified via a HisTrap HP column. PfTrpA was purified via a Q HP HiTrap column (flow-through), followed by ammonium sulfate precipitation, and hydrophobic interaction chromatography on a phenyl Sepharose HP HiTrap column (Fig. S6) .
Library Construction and High-Throughput Screening. Error-prone PCR libraries were constructed using standard protocols with either MnCl 2 or Mutazyme II (Stratagene). DNA shuffling and site-directed mutagenesis by overlap extension (SOE) PCR were performed to recombine activating mutations. The resulting libraries were cloned into pET22(b)+ with the C-terminal his-tag for expression in E. coli BL21 E. cloni EXPRESS cells. High-throughput expression and screening were performed on 96-well scale. Formation of L-tryptophan was recorded at 290 nm.
Kinetics and UV-Vis Spectroscopy. Data were collected between 550 and 250 nm on a UV1800 Shimadzu spectrophotometer (Shimadzu) using 0.25-20 μM of enzyme in 200 mM potassium phosphate (pH 8.0) in a quartz cuvette. Samples were incubated at 75°C for >3 min to ensure a stable temperature was reached. PfTrpB activity (k cat ) was measured by monitoring tryptophan formation at 290 nm using Δe 290 = 1.89 mM −1 ·cm −1 (15) .
Substrate Selectivity. The relative rate of NCAA production was measured using 20 mM L-serine and 20 mM indole analog (Fig. 5A ) in 200 mM potassium phosphate (pH 8.0) with 5% (vol/vol) DMSO. Reactions were incubated at 75°C for 1 h, quenched, and the relative rate of production formation was measured by comparing the ratio of the product peaks measured via ultra HPLC-MS (UHPLC-MS) Agilent 1290 with 6140 MS detector at 280 nm and then normalizing for the enzyme concentration.
Crystallography. Crystals of PfTrpB and PfTrpS were grown using the sittingdrop vapor diffusion method, and cryoprotected before diffraction at the Stanford Synchrotron Radiation Laboratories on beamline 12-2. Ligandbound crystals of PfTrpB were prepared by soaking preformed crystals with a concentrated solution of L-Ser or L-Trp. Structures were determined by molecular replacement and models were built using standard procedures.
Identification of Nonnatural Amino Acid Products. Preparative-scale reactions were conducted using PfTrpB 0B2 , which was prepared as a heat-treated lysate. Products were purified directly on C-18 silica, and their identities confirmed by 1 H NMR and low-resolution mass spectrometry (LRMS). The optical purity of the products was estimated by derivatization with N-(5-fluoro-2, 4-dinitrophenyl)alanamide (FDNP-alanamide).
